HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,564,750 | +43.8% | 27,500 | 0.0% | 0.02% | +60.0% |
| Q3 2022 | $1,088,000 | -47.4% | 27,500 | -46.9% | 0.02% | -40.0% |
| Q1 2022 | $2,068,000 | +13.9% | 51,800 | +29.5% | 0.02% | +4.2% |
| Q2 2021 | $1,816,000 | -55.0% | 40,000 | -58.7% | 0.02% | -72.4% |
| Q1 2021 | $4,035,000 | +86.8% | 96,800 | -19.3% | 0.09% | -28.7% |
| Q1 2020 | $2,160,000 | -66.5% | 120,000 | -67.0% | 0.12% | -43.5% |
| Q4 2019 | $6,446,000 | +109.6% | 363,500 | +83.4% | 0.22% | +34.2% |
| Q3 2019 | $3,076,000 | +496.1% | 198,200 | +560.7% | 0.16% | +519.2% |
| Q2 2019 | $516,000 | +13.7% | 30,000 | +20.0% | 0.03% | +4.0% |
| Q3 2018 | $454,000 | -97.9% | 25,000 | -97.6% | 0.02% | -98.9% |
| Q4 2017 | $21,429,000 | – | 1,057,700 | – | 2.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
| First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
| SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
| Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
| Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
| Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
| DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
| Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
| Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |